1992
DOI: 10.1093/jat/16.2.109
|View full text |Cite
|
Sign up to set email alerts
|

A Procedure for Eliminating Interferences from Ephedrine and Related Compounds in the GC/MS Analysis of Amphetamine and Methamphetamine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

1993
1993
2019
2019

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…4-CB, PFPA and HFBA have been reported [40]. Degradation of EPH and PEP by addition of sodium periodate prior to extraction has been recommended [41] and is an acceptable option for exclusive forensic confirmation of AMP and MET. Simultaneous detection of MCA alongside AMP and MET is however excluded, as the proposed reaction also destroys MCA [10] and is therefore not applicable in a multi-analyte confirmation procedure that includes MCA.…”
Section: Discussionmentioning
confidence: 99%
“…4-CB, PFPA and HFBA have been reported [40]. Degradation of EPH and PEP by addition of sodium periodate prior to extraction has been recommended [41] and is an acceptable option for exclusive forensic confirmation of AMP and MET. Simultaneous detection of MCA alongside AMP and MET is however excluded, as the proposed reaction also destroys MCA [10] and is therefore not applicable in a multi-analyte confirmation procedure that includes MCA.…”
Section: Discussionmentioning
confidence: 99%
“…The drug was first synthesized in Japan (Ogata, 1919) and later licensed as the anorectic Methedrine® (Logan, 2002). It is a central nervous system (CNS) stimulant and its potent stimulating effects appear to result by promoting the release of biogenic amines from their stores in the nerve terminals, together with dopamine (DA) release from dopaminergic nerve terminals (Elsohly et al, 1992). These effects can result in arrhythmia, vasculature constriction and delayed ejaculation and enhanced intensity of orgasm in male human (Perez-Reyes et al, 1991;Logan, 2002;Ellinwood and Kilbey, 1980).…”
Section: Methamphetaminementioning
confidence: 99%
“…Concern in workplace urine drug-testing programs has centered around the ability of an assay method to differentiate methamphetamine and ephedrine because both have similar chromatographic and mass spectral properties and there was some evidence that large amounts of ephedrine would form methamphetamine under high injection-port temperatures when derivatized using 4-carboxyhexaflurobutryl chloride (25,26) or heptaflurobutyric anhydride (26). One report (27) suggested removing the offending ephedrine by a metaperiodate oxidation prior to GC-MS analysis, and this has been recommended in the workplace drug-testing programs (26), but the pH must be controlled to prevent amphetamine artifact when methamphetamine is present (28). This application has little value in a clinical toxicology situation where the identity of an co-hydroxyl phenylethylamine is important in establishing a differential diagnosis, guiding subsequent therapeutic intervention, and providing effective patient or caregiver counseling.…”
Section: Introductionmentioning
confidence: 99%